Back to companies

Hangzhou Tigermed Consulting Co Ltd: Premium Databases

Hangzhou Tigermed Consulting Co Ltd Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

A sample of Hangzhou Tigermed Consulting Co Ltd Insights data

Headline Published Journalists
Showing 3 of 5 results. Subscribe to unlock more.
Deserunt mollit sunt Lorem laborum do id aliqua dolore 12 Dec 2017 Lorem
Azaya shops CMOs for Phase II NSCLC study of liposomal docetaxel formulation - CEO 09 May 2014 Casey McDonald
Guangzhou Boji Pharma seeks global CRO partners, IPO expected next year – exec 04 Nov 2013 Ying Huang
Daewoong Pharmaceutical hires three Chinese CROs for product registration - source 25 Oct 2013 Ying Huang
Insights

Feature

Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.

Benefit

Drug Insights:

  • Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
  • Material intelligence on competitors, including breaking news
  • Insight on companies’ business development needs and strategies

Outsourcing Insights:

Insight on companies’ CRO and business development needs, strategies and relationships

Value

Remove risk and uncertainty

Gain a competitive edge

Secure actionable leads

Premium databases is part of our industry range of products

Subscribe to Company Analytics & gain 12-month access to premium industry data & analytics
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer